305 related articles for article (PubMed ID: 36831673)
21. Assessment of Exocrine Function of Pancreas Following Pancreaticoduodenectomy.
Thogari K; Tewari M; Shukla SK; Mishra SP; Shukla HS
Indian J Surg Oncol; 2019 Jun; 10(2):258-267. PubMed ID: 31168245
[TBL] [Abstract][Full Text] [Related]
22. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency.
; Smith RC; Smith SF; Wilson J; Pearce C; Wray N; Vo R; Chen J; Ooi CY; Oliver M; Katz T; Turner R; Nikfarjam M; Rayner C; Horowitz M; Holtmann G; Talley N; Windsor J; Pirola R; Neale R
Pancreatology; 2016; 16(2):164-80. PubMed ID: 26775768
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines-A cross-sectional observational study.
Erchinger F; Tjora E; Nordaas IK; Dimcevski G; Olesen SS; Jensen N; Dahl EE; Borch A; Nøjgaard C; Novovic S; Barauskas G; Ignatavicius P; Vujasinovic M; Lőhr M; Laukkarinen J; Parhiala M; Drewes AM; Engjom T
United European Gastroenterol J; 2022 Oct; 10(8):844-853. PubMed ID: 35981311
[TBL] [Abstract][Full Text] [Related]
24. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
Roberts KJ; Bannister CA; Schrem H
Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188
[TBL] [Abstract][Full Text] [Related]
25. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
[TBL] [Abstract][Full Text] [Related]
26. Nutrition in children with exocrine pancreatic insufficiency.
Zheng Y; Mostamand S
Front Pediatr; 2023; 11():943649. PubMed ID: 37215591
[TBL] [Abstract][Full Text] [Related]
27. Supportive care in pancreatic ductal adenocarcinoma.
Laquente B; Calsina-Berna A; Carmona-Bayonas A; Jiménez-Fonseca P; Peiró I; Carrato A
Clin Transl Oncol; 2017 Nov; 19(11):1293-1302. PubMed ID: 28612201
[TBL] [Abstract][Full Text] [Related]
28. Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma.
McDonnell D; Afolabi PR; Wilding S; Griffiths GO; Swann JR; Byrne CD; Hamady ZZ
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136302
[TBL] [Abstract][Full Text] [Related]
29. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency.
Nakajima K; Oshida H; Muneyuki T; Kakei M
Core Evid; 2012; 7():77-91. PubMed ID: 22936895
[TBL] [Abstract][Full Text] [Related]
30. The Population-level Prevalence of Exocrine Pancreas Insufficiency and the Subsequent Risk of Pancreatic Cancer.
Babajide O; Desai A; Eruchalu C; Sedarous M; Adekunle D; Youssef M; Mahmud M; Okafor PN
Pancreas; 2024 May; ():. PubMed ID: 38696443
[TBL] [Abstract][Full Text] [Related]
31. Update on the diagnosis and management of exocrine pancreatic insufficiency.
Perbtani Y; Forsmark CE
F1000Res; 2019; 8():. PubMed ID: 31824646
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus
Trestini I; Carbognin L; Peretti U; Sperduti I; Caldart A; Tregnago D; Avancini A; Auriemma A; Orsi G; Pilotto S; Frulloni L; Capurso G; Bria E; Reni M; Tortora G; Milella M
Front Oncol; 2021; 11():688889. PubMed ID: 34568019
[TBL] [Abstract][Full Text] [Related]
33. Fecal fat and energy loss in pancreas exocrine insufficiency: the role of pancreas enzyme replacement therapy.
Erchinger F; Øvre AKN; Aarseth MM; Engjom T; Brønstad I; Dimcevski G; Gudbrandsen OA; Tjora E
Scand J Gastroenterol; 2018 Sep; 53(9):1132-1138. PubMed ID: 30193081
[TBL] [Abstract][Full Text] [Related]
34. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease.
Kulkarni NM; Soloff EV; Tolat PP; Sangster GP; Fleming JB; Brook OR; Wang ZJ; Hecht EM; Zins M; Bhosale PR; Arif-Tiwari H; Mannelli L; Kambadakone AR; Tamm EP
Abdom Radiol (NY); 2020 Mar; 45(3):716-728. PubMed ID: 31748823
[TBL] [Abstract][Full Text] [Related]
35. Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma.
Schnipper J; Dhennin-Duthille I; Ahidouch A; Ouadid-Ahidouch H
Front Pharmacol; 2020; 11():568993. PubMed ID: 33178018
[TBL] [Abstract][Full Text] [Related]
36. The Pancreatic Duct Ligated (Mini)pig as a Model for Pancreatic Exocrine Insufficiency in Man.
Gregory PC; Hoffmann K; Kamphues J; Möeler A
Pancreas; 2016 Oct; 45(9):1213-26. PubMed ID: 27623555
[TBL] [Abstract][Full Text] [Related]
37. Prospective trial to evaluate the prognostic value of different nutritional assessment scores for survival in pancreatic ductal adenocarcinoma (NURIMAS Pancreas SURVIVAL).
Heckler M; Klaiber U; Hüttner FJ; Haller S; Hank T; Nienhüser H; Knebel P; Diener MK; Hackert T; Büchler MW; Probst P
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1940-1947. PubMed ID: 34545696
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiome and pancreatic cancer cachexia: An evolving relationship.
Hendifar A; Akinsola R; Muranaka H; Osipov A; Thomassian S; Moshayedi N; Yang J; Jacobs J; Devkota S; Bhowmick N; Gong J
World J Gastrointest Oncol; 2022 Jul; 14(7):1218-1226. PubMed ID: 36051103
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management.
Dunleavy L; Al-Mukhtar A; Halliday V
Clin Nutr ESPEN; 2018 Aug; 26():97-103. PubMed ID: 29908691
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic Exocrine Insufficiency in Pancreatic Cancer.
Vujasinovic M; Valente R; Del Chiaro M; Permert J; Löhr JM
Nutrients; 2017 Feb; 9(3):. PubMed ID: 28241470
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
